🔎 Trials Near Me

Akèy › Kolit Ulseratif › Kalifòni › Los Angeles

Etid klinik pou Kolit Ulseratif nan Los Angeles, CA

13 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • TLC Clinical Research Inc, Los Angeles
  • GastroIntestinal Bioscience, Los Angeles
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Ap rekriteFaz 2/3
  • Cedars-Sinai Medical Center, Los Angeles
Laj 2 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT05076175

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Ap rekriteFaz 2
  • Biopharma Informatic, LLC, Los Angeles
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Ap rekriteFaz 2
  • Biopharma Informatic, LLC, Los Angeles
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483073

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ap rekriteFaz 4
  • Cedars-Sinai Medical Center, Los Angeles
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • TLC Clinical Research Inc. - Site Number: 8400030, Los Angeles
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation

Ap rekrite
  • Cedars Sinai Medical Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT07034443

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Ap rekrite
  • Cedars-Sinai, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

Ap rekrite
  • Center for Colorectal Innovation, Los Angeles
Laj 18 a 85 · Tout sèks · Mizajou Aug 6, 2026 · NCT06571669

The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

Ap rekriteFaz 2
  • Children's Hospital Los Angeles, Los Angeles
Laj 7 a 21 · Tout sèks · Mizajou Jun 4, 2026 · NCT05218850

Impact of Prebiotics in Ulcerative Colitis

Ap rekrite
  • UCLA, Los Angeles
Laj 18 a 85 · Tout sèks · Mizajou Feb 27, 2026 · NCT06495658

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Ap rekrite
  • University of Los Angeles Health, Los Angeles
Laj 18 a 85 · Tout sèks · Mizajou Jan 8, 2026 · NCT05987852

Effects of Pomegranate Juice on Ulcerative Colitis

Ap rekrite
  • West Los Angeles VA Medical Center, Los Angeles
  • UCLA Center for Human Nutrition, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Dec 9, 2025 · NCT07115862

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.